SARS-CoV-2感染后后遗症的免疫治疗

World Journal of Neuroscience Pub Date : 2020-04-09 DOI:10.4236/wjns.2020.102013

D. Younger

{"title":"SARS-CoV-2感染后后遗症的免疫治疗","authors":"D. Younger","doi":"10.4236/wjns.2020.102013","DOIUrl":null,"url":null,"abstract":"The SARS-CoV-2 2019 pandemic is creating challenges \nto the management of post-infectious autoimmunity in childhood and adult \nCovid-19 cases due to its high case fatality. Nearly all of the agents \nenvisioned to treat Covid-19 illness, including the newly recognized pediatric \nmulti-system inflammatory syndrome, impact post-infectious mechanisms in \nkeeping with the multiplier effect of infection, immunity and inflammation, \nknown as I-Cubed (I3).","PeriodicalId":23878,"journal":{"name":"World Journal of Neuroscience","volume":"281 1","pages":"117-120"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Immunotherapy for the Post-Infectious Sequela of SARS-CoV-2 Infection\",\"authors\":\"D. Younger\",\"doi\":\"10.4236/wjns.2020.102013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The SARS-CoV-2 2019 pandemic is creating challenges \\nto the management of post-infectious autoimmunity in childhood and adult \\nCovid-19 cases due to its high case fatality. Nearly all of the agents \\nenvisioned to treat Covid-19 illness, including the newly recognized pediatric \\nmulti-system inflammatory syndrome, impact post-infectious mechanisms in \\nkeeping with the multiplier effect of infection, immunity and inflammation, \\nknown as I-Cubed (I3).\",\"PeriodicalId\":23878,\"journal\":{\"name\":\"World Journal of Neuroscience\",\"volume\":\"281 1\",\"pages\":\"117-120\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-04-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Neuroscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4236/wjns.2020.102013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4236/wjns.2020.102013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

2019年SARS-CoV-2大流行由于病死率高，给儿童和成人Covid-19病例的感染后自身免疫管理带来了挑战。几乎所有预计用于治疗Covid-19疾病的药物，包括新发现的儿科多系统炎症综合征，都会影响感染后机制，以保持感染、免疫和炎症的乘数效应，即i- cube (I3)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Immunotherapy for the Post-Infectious Sequela of SARS-CoV-2 Infection

The SARS-CoV-2 2019 pandemic is creating challenges to the management of post-infectious autoimmunity in childhood and adult Covid-19 cases due to its high case fatality. Nearly all of the agents envisioned to treat Covid-19 illness, including the newly recognized pediatric multi-system inflammatory syndrome, impact post-infectious mechanisms in keeping with the multiplier effect of infection, immunity and inflammation, known as I-Cubed (I3).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

World Journal of Neuroscience

自引率

0.00%

发文量